Immune Checkpoint Inhibitor Therapy in a Liver Transplant Recipient With Melanoma

Ann Intern Med. 2017 Sep 5;167(5):361-362. doi: 10.7326/L17-0187. Epub 2017 Aug 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antineoplastic Agents, Immunological / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Biopsy
  • Combined Modality Therapy
  • Disease Progression
  • Hepatitis C / drug therapy*
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / therapeutic use
  • Lip Neoplasms / pathology
  • Lip Neoplasms / therapy*
  • Liver Function Tests
  • Liver Transplantation*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / secondary*
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Mycophenolic Acid / therapeutic use
  • Neoplasm Staging
  • Steroids / therapeutic use

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents, Immunological
  • Antiviral Agents
  • Immunosuppressive Agents
  • Steroids
  • pembrolizumab
  • Mycophenolic Acid